Methyl morpholine oxide → tert-Butyl 2-formylpiperidine-1-carboxylate
反応式
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH2:11][CH2:10][CH:9]1[CH2:14][OH:15])=[O:7])([CH3:4])([CH3:3])[CH3:2].C[N+]1([O-])CCOCC1>C(Cl)Cl.[Ru]([O-])(=O)(=O)=O.C([N+](CCC)(CCC)CCC)CC>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH2:11][CH2:10][CH:9]1[CH:14]=[O:15])=[O:7])([CH3:4])([CH3:3])[CH3:2]参加物
5
実験手順
To a stirred solution of 2-hydroxymethyl-piperidine-1-carboxylic acid tert-butyl ester (0.737 g, 3.4 mmol) in dry CH2Cl2 (10 mL) was added 3 A molecular sieves (1.03 g), N-methylmorpholine N-oxide (0.644 g, 5.5 mmol), and tetrapropylammonium perruthenate (72 mg, 0.21 mmol) and the mixture stirred at room temperature for 3 h. The reaction mixture was purified through a silica gel plug (Hexanes/EtOAc, 70:30 followed by 100:0) to afford the title aldehyde (0.500 g, 70%) as a pale yellow oil.
後処理
- customThe reaction mixture was purified through a silica gel plug (Hexanes/EtOAc, 70:30 followed by 100:0)
出典と根拠
- ORDレコード
- ord-c299e239208b4e118cbb682e4d173a69
- 出典データセット
- uspto-grants-2008_04
- 特許番号
- US07354932B2
反応ノート
読み込み中…